Stock Region Penny Picks
Stock Region Penny Picks Watchlist Newsletter - Wednesday, February 12, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: The information provided in this newsletter is for educational purposes only and should not be considered financial advice. Please conduct your own research or consult with a financial advisor before making investment decisions.
$APTO – Aptose Biosciences
Aptose’s frontline triple drug therapy, including Tuspetinib, showed notable responses in newly diagnosed AML patients during its Phase 1/2 TUSCANY trial. This progress could signal growing potential for Aptose in the oncology treatment space.
$NXU – Nxu, Inc.
Nxu has received shareholder approval for its merger with Verde Bioresins. This merger is expected to broaden the company’s operational and market capabilities.
$NEUP – Neuphoria Therapeutics Inc.
Neuphoria Therapeutics will receive a $15M milestone payment from Merck. This payment likely reflects steady advancement and successful partnership outcomes for the company.
$XLO – Xilio Therapeutics
Xilio Therapeutics has entered a collaboration and option agreement with AbbVie for the development of tumor-activated immunotherapies. This partnership could unlock innovative cancer treatment approaches.
$BDRX – Biodexa Pharmaceuticals
Biodexa’s FAP drug has been granted FDA Fast Track status following promising Phase 2 trial results and orphan drug designation.
$GNS – Genius Group
Genius Group has called an extraordinary general meeting (EGM) to approve a share buyback and confirmed the cancellation of its rights offering. A buyback program could signal confidence in the company’s financial position and future outlook.
$NKGN – NKGen Biotech
NKGen Biotech secured FDA Fast Track designation for Troculeucel, aimed at treating moderate Alzheimer’s disease. This designation may enable faster drug development and regulatory review.
$ANRO – Alto Neuroscience
Alto Neuroscience has reported favorable interim results from its Phase 2b trial of ALTO-300 for major depressive disorder, further solidifying its potential role as a key player in mental health treatment innovation.
$TIVC – Tivic Health
Tivic Health has acquired worldwide rights for a Phase III TLR5 agonist from Statera Biopharma. This decision positions Tivic to further enhance its therapeutic pipeline.
$AGH – Aureus Greenway Holdings Inc.
Aureus Greenway Holdings IPO launched at $4.35. The company operates golf country clubs in Florida, designed to attract both local and tourist audiences with diverse offerings in leisure spending.
$BPTH – Bio-Path Holdings
Bio-Path Holdings announced positive patient responses in its clinical trial and has advanced to a higher dose cohort of 90 mg/m2. The trial's progression demonstrates promising therapeutic potential.
$CNTM – ConnectM
ConnectM raised its Q4 ‘24 revenue guidance to $9M, a 102% year-over-year increase, exceeding previous estimates by $2M. The company also adjusted its FY2024 revenue guidance to $26.3M and expects to provide Q1 ‘25 guidance soon.
Happy investing!
Stock Region Team
Disclaimer: This newsletter is for informational purposes only and does not constitute financial advice. Always perform your own due diligence or consult with a financial advisor.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net